Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

Trial II 

CMF + prednisone combined with or without oophorectomy for pre/perimenopausal patients with breast cancer and 4 or more positive nodes.

DESIGN

Design Trial II

Results & Publications


Presentations


Publications

Study Chair
Prof. Aron Goldhirsch - Milano, Italy

Statistician
Karen Price

Trial Coordinators
Joie Celano, Meghan Metz, Kris Rickard, Tara Scolese
IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsgI-IV@fstrf.org

Date of Activation
July 1, 1978

Date of Closure
September 1, 1981

Final Accrual
1713 patients (1601 evaluable patients)


Results Publications Results & Publications


News

27.08.2010:
Activation of IBCSG Trial 38-10/BIG 3-07/TROG 07.01

19.08.2010:
A few impressions from our audits

09.08.2010:
Latest SOLE flash

All News

 
  Print